| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase-1 POSITIVE ION MODE | MO_33 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_34 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_35 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_36 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_37 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_38 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_39 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_40 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_41 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_42 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_43 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_44 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | P0_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | P0_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | P17A_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | P17A_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | P17B_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | P17B_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | P17C_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | P17C_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180 Cal1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180 Cal2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180 Cal3 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180 Cal4 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180 Cal5 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180 Cal6 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180 Cal7 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180-MetaDis QC1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180-MetaDis QC2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | p180-MetaDis QC3 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | PBS_01 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | PBS_02 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | PBS_03 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | TP_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | TP_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | TP_3 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_25 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_26 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_27 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_28 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_29 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_30 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_31 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_32 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_13 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_14 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_15 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_16 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_17 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_18 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_19 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_20 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_21 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_22 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_23 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_24 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_1 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_10 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_11 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_12 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_2 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_3 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_4 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_5 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_6 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_7 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_8 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-1 POSITIVE ION MODE | MO_9 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_33 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_34 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_35 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_36 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_37 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_38 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_39 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_40 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_41 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_42 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_43 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_44 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | P0_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | P0_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | P17A_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | P17A_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | P17B_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | P17B_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | P17C_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | P17C_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180 Cal1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180 Cal2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180 Cal3 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180 Cal4 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180 Cal5 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180 Cal6 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180 Cal7 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180-MetaDis QC1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180-MetaDis QC2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | p180-MetaDis QC3 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | PBS_01 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | PBS_02 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | PBS_03 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | TP_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | TP_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | TP_3 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_25 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_26 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_27 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_28 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_29 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_30 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_31 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_32 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_13 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_14 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_15 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_16 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_17 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_18 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_19 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_20 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_21 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_22 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_23 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_24 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_1 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_10 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_11 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_12 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_2 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_3 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_4 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_5 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_6 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_7 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_8 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase-2 POSITIVE ION MODE | MO_9 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_33 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_34 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_35 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_36 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_37 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_38 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_39 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_40 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_41 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_42 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_43 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_44 | MCV:Act KLH | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | P0_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | P0_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | P17A_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | P17A_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | P17B_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | P17B_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | P17C_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | P17C_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180 Cal1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180 Cal2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180 Cal3 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180 Cal4 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180 Cal5 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180 Cal6 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180 Cal7 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180-MetaDis QC1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180-MetaDis QC2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | p180-MetaDis QC3 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | PBS_01 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | PBS_02 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | PBS_03 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | TP_1 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | TP_2 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | TP_3 | MCV:- | Adjuvant:- | Sample Collection:- | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_25 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_26 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_27 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_28 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_29 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_30 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_31 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_32 | MCV:SSM09 | Adjuvant:None | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_13 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_14 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_15 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_16 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_17 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_18 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_19 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_20 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_21 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_22 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_23 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_24 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Immunized (17 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_1 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_10 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_11 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_12 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_2 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_3 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_4 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_5 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_6 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_7 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_8 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
| Reversed phase NEGATIVE ION MODE | MO_9 | MCV:SSM09 | Adjuvant:RIBI | Sample Collection:Pre-Immune (0 wks) | Peak intensity |
Return to study ST000456 main page
Download data matrix(Metabolomic changes during active immunization with anti-METH vaccines. Reversed phase-1 POSITIVE ION MODE)
Download data matrix(Metabolomic changes during active immunization with anti-METH vaccines. Reversed phase-2 POSITIVE ION MODE)
Download data matrix(Metabolomic changes during active immunization with anti-METH vaccines. Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|